Dose Distribution Analysis in Stereotactic Body Radiotherapy Using Dynamic Conformal Multiple Arc Therapy-Reference-Cited by-同舟云学术

Dose Distribution Analysis in Stereotactic Body Radiotherapy Using Dynamic Conformal Multiple Arc Therapy

Published:2009-06 Issue:2 Volume:74 Page:363-369
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Takeda Atsuya,Kunieda Etsuo,Sanuki Naoko,Ohashi Toshio,Oku Yohei,Sudo Yasunobu,Iwashita Hideo,Ooka Yoshikazu,Aoki Yosuke,Shigematsu Naoyuki,Kubo Atsushi

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference32 articles.

1. Computed tomography-guided frameless stereotactic radiotherapy for stage I non–small-cell lung cancer: A 5-year experience;Uematsu;Int J Radiat Oncol Biol Phys,2001

2. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study;Onishi;Cancer,2004

3. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame;Nagata;Int J Radiat Oncol Biol Phys,2005

4. Stereotactic body radiotherapy (SBRT) for primary lung cancer at a dose of 50 Gy total in 5 fractions to the periphery of the planning target volume (PTV) calculated using asuperposition algorithm;Takeda;Int J Radiat Oncol Biol Phys,2009

5. Current status of stereotactic body radiotherapy for lung cancer;Nagata;Int J Clin Oncol,2007

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dose-volume comparisons of proton therapy for pencil beam scanning with and without multi-leaf collimator and passive scattering in patients with lung cancer;Medical Dosimetry;2023-11

2. Limites de la définition des contraintes de dose pour les organes à risque spécifiques à la radiothérapie stéréotaxique;Cancer/Radiothérapie;2023-06

3. Clinical Experience of Intra-tumoral Central-Dose Escalated Volumetric Modulated Arc Therapy for Lymph Node Metastases in Patients With Advanced Cancer;Cureus;2023-02-14

4. CT Findings and Treatment Outcomes of Ground-Glass Opacity Predominant Lung Cancer After Stereotactic Body Radiotherapy;Clinical Lung Cancer;2022-07

5. Impact of local recurrence on cause-specific death after stereotactic body radiotherapy for early-stage non-small cell lung cancer: dynamic prediction using landmark model;International Journal of Radiation Oncology*Biology*Physics;2021-11